Knoll, R., Helbig, E. T., Dahm, K., Bolaji, O., Hamm, F., Dietrich, O., . . . Kurth, F. (2024). The life-saving benefit of dexamethasone in severe COVID-19 is linked to a reversal of monocyte dysregulation. Cell, 187(16), 4318-4335. https://doi.org/10.1016/j.cell.2024.06.014
Chicago Style (17th ed.) CitationKnoll, Rainer, et al. "The Life-saving Benefit of Dexamethasone in Severe COVID-19 Is Linked to a Reversal of Monocyte Dysregulation." Cell 187, no. 16 (2024): 4318-4335. https://doi.org/10.1016/j.cell.2024.06.014.
MLA (8th ed.) CitationKnoll, Rainer, et al. "The Life-saving Benefit of Dexamethasone in Severe COVID-19 Is Linked to a Reversal of Monocyte Dysregulation." Cell, vol. 187, no. 16, 2024, pp. 4318-4335, https://doi.org/10.1016/j.cell.2024.06.014.
Warning: These citations may not always be 100% accurate.
Visit our Citation Styles guide for help on properly citing sources.
Visit our Citation Styles guide for help on properly citing sources.